Roger Song

Stock Analyst at Jefferies

(0)
# 4855
Out of 5,218 analysts
41
Total ratings
25.93%
Success rate
-27.49%
Average return
26 Stocks
Name Action Price Target Current % Upside Ratings Updated
Bioage Labs
Downgrades: Hold
42 7
n/a n/a 2 Dec 9, 2024
Replimune Group
Maintains: Strong Buy
16 19
12.53 51.64% 1 Dec 4, 2024
Kura Oncology
Maintains: Buy
32 28
9.6 191.67% 2 Nov 21, 2024
Aclaris Therapeutics
Upgrades: Buy
2 7
3.23 116.72% 1 Nov 19, 2024
Disc Medicine
Initiates Coverage On: Buy
89
64.78 37.39% 1 Oct 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
31 25
9.12 174.12% 2 Oct 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
41
20.21 102.87% 1 Oct 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
35
8.94 291.5% 1 Oct 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
40
20.26 97.43% 1 Sep 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
9
3.06 194.12% 1 Sep 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
108 129
87.74 47.03% 1 Sep 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
3 8
1.08 640.74% 3 May 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
97
86.68 11.91% 1 Apr 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
41 72
21.89 228.92% 2 Mar 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
110
46.98 134.14% 1 Mar 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
1 1
1 0% 7 Mar 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
31 2
n/a n/a 2 Sep 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
61 55
7.52 631.38% 1 Nov 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
30 35
8.98 289.76% 1 Aug 31, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
9
0.8 1025% 1 Jul 29, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
675
2.4 28025% 1 Jan 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
8
7.35 8.84% 2 Dec 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
3 4
0.24 1566.67% 2 Nov 12, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
30
n/a n/a 1 Feb 8, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
315
0.4 78650% 1 Sep 8, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
21
2.11 895.26% 1 Sep 2, 2020